CW
Changping Wu

Publications (1)

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Article scientifique · 2017

Domaines principaux

Sciences de la santé1

Statistiques

Consultations2
Téléchargements0